The risk of cardiovascular events associated with inhaled long-acting beta-2-adrenoreceptor agonists in patients with chronic obstructive pulmonary disease

被引：1
|
作者：
Ogale, Sarika S. [1 ]
Lee, Todd A. [1 ]
Sullivan, Sean D. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
CHEST | 2006年 / 130卷 / 04期
关键词：
D O I：
10.1378/chest.130.4_MeetingAbstracts.121S-d
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：121S / 122S
页数：2
相关论文
共 50 条
  • [31] Long-Acting Bronchodilators and Risk of Adverse Cardiovascular Events in Chronic Obstructive Pulmonary Disease: A Focused Critical Review
    Tao, Sunning
    Kirsch, Erika
    Yeomans, Karen
    Sigler, Catherine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 456 - 457
  • [32] LONG-ACTING BRONCHODILATORS AND RISK OF ADVERSE CARDIOVASCULAR EVENTS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A FOCUSED CRITICAL REVIEW
    Tao, S.
    Kirsch, E.
    Yeomans, K.
    Sigler, C.
    VALUE IN HEALTH, 2015, 18 (03) : A169 - A169
  • [33] RISK OF CAR DIOVASCULAR DISEASES FROM ADD-ON OF INHALED TIOTROPIUM TO COMBINED THERAPY OF INHALED CORTICOSTEROIDS AND LONG-ACTING BETA-AGONISTS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS
    Wang, M.
    Tsai, C.
    Wu, B.
    Lin, C. W.
    Wang, Y.
    VALUE IN HEALTH, 2016, 19 (03) : A110 - A110
  • [34] Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease (COPD) Occurrence Frequency and the Effect of Treatment With the Inhaled Long-Acting Beta2-Agonists Arformoterol and Salmeterol
    Hanrahan, John P.
    Grogan, Donna R.
    Baumgartner, Rudolf A.
    Wilson, Amy
    Cheng, Hailong
    Zimetbaum, Peter J.
    Morganroth, Joel
    MEDICINE, 2008, 87 (06) : 319 - 328
  • [35] Long-Acting β-Agonist/Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease with Cardiovascular Disease or Risk: A Factorial Analysis of the SUMMIT Clinical Trial
    Celli, Bartolome
    Anderson, Julie A.
    Brook, Robert
    Calverley, Peter
    Crim, Courtney
    Holmes, Andrew P.
    Martinez, Fernando J.
    Newby, David E.
    Yates, Julie
    Vestbo, Jorgen
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (12) : 1641 - 1644
  • [36] Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonists for chronic obstructive pulmonary disease
    Javier Nannini, Luis
    Lasserson, Toby J.
    Poole, Phillippa
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):
  • [37] Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease A Nested Case-Control Study
    Wang, Meng-Ting
    Liou, Jun-Ting
    Lin, Chen Wei
    Tsai, Chen-Liang
    Wang, Yun-Han
    Hsu, Yu-Juei
    Lai, Jyun-Heng
    JAMA INTERNAL MEDICINE, 2018, 178 (02) : 229 - 238
  • [38] Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease
    Appleton, S.
    Jones, T.
    Poole, P.
    Pilotto, L.
    Adams, R.
    Lasserson, T. J.
    Smith, B.
    Muhammad, J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (03):
  • [39] Comparative Effectiveness of Long-Acting Beta2-Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease
    Samp, Jennifer C.
    Joo, Min J.
    Schumock, Glen T.
    Calip, Gregory S.
    Pickard, A. Simon
    Lee, Todd A.
    PHARMACOTHERAPY, 2017, 37 (04): : 447 - 455
  • [40] Tiotropium: An inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease
    Panning, CA
    DeBisschop, M
    PHARMACOTHERAPY, 2003, 23 (02): : 183 - 189
12345